Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

RACK1 (D59D5) Rabbit mAb (BSA and Azide Free)


Cell Signalling Technology logo
View Antibody details

Racotumomab Biosimilar – Anti-Idiotope of anti-(N-glycolylneuraminic acid (NeuGc/NGNA) -gangliosides GM3) Mus musculus IgM-kappa monoclonal antibody P3 mAb – Research Grade


View Antibody details

Rad17 (D3G6) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Rad18 (D2B8) XP® Rabbit mAb


Cell Signalling Technology logo
View Antibody details

RAD21 (D5Y8S) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Rad21 antibody [HL2171]


Genetex logo
View Antibody details

Rad23A (D7U7Z) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Rad23B (D4W7F) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Rad50 (E3I8K) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Rad50 (E4J5R) Rabbit mAb


Cell Signalling Technology logo
View Antibody details